Opinion Former Articles
Breast Cancer Care’s statement on the NICE draft guidance on Perjeta (pertuzumab) for this week is below.
Breast Cancer Care’s statement on the NICE draft guidance on Perjeta (pertuzumab) for this week is below. Please get in touch for any further information.
“Intrabeam radiotherapy is another exciting development and could dramatically improve the quality of life of some women diagnosed with breast cancer, but there is not yet evidence of its long term benefits".
Training and education for prescribers and information for patients must be implemented to halt the rise of superbugs and over-prescribing of antibiotics
MRSA Action UK welcome the NICE guidance on antimicrobial stewardship, and in our response to NICE, have emphasised the need for better diagnostics so that when someone does need treatment they get the right targeted antimicrobial if its required.
MRSA Action UK supported the development of the guideline on the prevention and control of healthcare associated infections, and welcomed the introduction of the quality statement on the requirement of judicious antimicrobial prescribing.